Lowering the Dose of Corticosteroid Regimen in Kidney Transplantation: Is It Effective in Decreasing Post-operative Surgical Complications?
Urology Journal,
Vol. 20 (2023),
25 Dey 2022
,
Page 7493
https://doi.org/10.22037/uj.v20i.7493
Abstract
Purpose: To investigate the impact of reducing post-operative oral corticosteroid regimen on associated postoperative surgical complication rate, patient and graft survival in kidney transplant patients.
Materials and Methods: In this retrospective cohort study, we enrolled patients who received kidney transplant during two periods of distinct corticosteroid protocols. 592 patients in group 1 received prednisone 2 mg/kg (maximum dose 120 mg) on post-operative days (POD) 1, 2 and 3, 1mg/kg for a week, and tapered it to 10 mg by 3 months post-transplant and sustained the daily 10mg from 3 months post-transplant as maintenance therapy. 639 patients in group 2 received prednisone 50 mg on POD 1, 40mg on POD 2, 30mg on POD 3, 20mg on POD 4, 15mg on POD 5 and continued with 10mg daily from POD 6, as maintenance therapy. The two groups were similar in terms of other immunosuppression drug regimen.
Results: 75 (12.7%) patients in group 1 and 24 (3.4%) patients in group 2 developed corticosteroid-related postoperative surgical complications (P < .001). Wound infection (P = .035), incisional hernia (P = .003), infectious collection (P = .004), post-op hemorrhage (P = .005) and ureteral fistula (P = .076) occurred with lower frequency in group 2. Patient survival (1-year: 97.3% vs 97.1%, respectively; P = .85, 5-year: 89.9% vs 94.9%, respectively; P = .06) and graft survival (1-year: 94.6% vs 93.3%, respectively; P = .29, 5-year: 81.2% vs 85.1%, respectively; P = .39) were similar in both groups.
Conclusion: Post-operative corticosteroid dosage decrement through our protocol would lessen the serious associated postoperative surgical complications, without negative impacts on overall patient and graft survival.
- kidney transplantation, corticosteroid, administration and dosage, postoperative complications, survival analysis
How to Cite
References
Tarantino A, Montagnino G, Ponticelli C. Corticosteroids in kidney transplant recipients. Safety issues and timing of discontinuation. Drug safety 1995; 13 (3): 145-156.
Citterio F. Steroid side effects and their impact on transplantation outcome. Transplantation 2001; 72 (12 Suppl): S75-80.
Yasir M, Goyal A, Sonthalia S. Corticosteroid Adverse Effects. StatPearls, Treasure Island (FL): StatPearls Publishing Copyright © 2022, StatPearls Publishing LLC. 2022.
Togo S, Nagano Y, Masumoto C et al. Outcome of and risk factors for incisional hernia after partial hepatectomy. J Gastrointest Surg 2008; 12 (6): 1115-1120.
Weisberger JS, Oleck NC, Ayyala HS et al. Analysis of the impact of chronic corticosteroid use on free flap reconstruction. Microsurgery 2021; 41 (1): 14-18.
Hasselgren PO, Säljö A, Fornander J et al. Postoperative wound infections in patients with long preoperative hospital stay. Acta Chir Scand 1982; 148 (6): 473-477.
Fink N, Segev A, Barbash I et al. Vascular complications in steroid treated patients undergoing transfemoral aortic valve implantation. Catheter Cardiovasc Interv 2016; 87 (2): 341-346.
Matas AJ. Minimization of steroids in kidney transplantation. Transplant international : official journal of the European Society for Organ Transplantation 2009; 22 (1): 38-48.
Prasad GV, Nash MM, McFarlane PA et al. Renal transplant recipient attitudes toward steroid use and steroid withdrawal. Clinical transplantation 2003; 17 (2): 135-139.
De Lucena DD, Rangel É B. Glucocorticoids use in kidney transplant setting. 2018; 14 (10): 1023-1041.
Hricik DE, Kupin WL, First MR. Steroid-free immunosuppression after renal transplantation. Journal of the American Society of Nephrology : JASN 1994; 4 (8 Suppl): S10-16.
Hricik DE, O'Toole MA, Schulak JA et al. Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: a meta-analysis. Journal of the American Society of Nephrology : JASN 1993; 4 (6): 1300-1305.
Ismael H, Horst M, Farooq M et al. Adverse effects of preoperative steroid use on surgical outcomes. Am J Surg 2011; 201 (3): 305-308; discussion 308-309.
Wang AS, Armstrong EJ, Armstrong AW. Corticosteroids and wound healing: clinical considerations in the perioperative period. Am J Surg 2013; 206 (3): 410-417.
Golub R, Golub RW, Cantu R, Jr. et al. A multivariate analysis of factors contributing to leakage of intestinal anastomoses. J Am Coll Surg 1997; 184 (4): 364-372.
Jeong H, Choi JW, Ahn HJ et al. The effect of preventive use of corticosteroids on postoperative complications after esophagectomy: A retrospective cohort study. Scientific Reports 2019; 9 (1): 11984.
Garmpis N, Spartalis E, Schizas D et al. Incisional Hernias Post Liver Transplantation: Current Evidence of Epidemiology, Risk Factors and Laparoscopic Versus Open Repair. A Review of the Literature. In Vivo 2019; 33 (4): 1059-1066.
Kahn J, Müller H, Iberer F et al. Incisional hernia following liver transplantation: incidence and predisposing factors. Clin Transplant 2007; 21 (3): 423-426.
Janssen H, Lange R, Erhard J et al. Causative factors, surgical treatment and outcome of incisional hernia after liver transplantation. Br J Surg 2002; 89 (8): 1049-1054.
Gómez R, Hidalgo M, Marques E et al. Incidence and predisposing factors for incisional hernia in patients with liver transplantation. Hernia 2001; 5 (4): 172-176.
Collins CG, Collins JH, Harrison BR et al. Early repair of vesicovaginal fistula. American Journal of Obstetrics and Gynecology 1971; 111 (4): 524-528.
Ahern MJ, Comite H, Andriole VT. Infectious complications associated with renal transplantation: an analysis of risk factors. Yale J Biol Med 1978; 51 (5): 513-525.
Khauli RB, Stoff JS, Lovewell T et al. Post-transplant lymphoceles: a critical look into the risk factors, pathophysiology and management. J Urol 1993; 150 (1): 22-26.
Adebiyi O, Umukoro P, Sharfuddin A et al. Patient and Graft Survival Outcomes During 2 Eras of Immunosuppression Protocols in Kidney Transplantation: Indiana University Retrospective Cohort Experience. Transplantation proceedings 2021; 53 (10): 2841-2852.
Luan FL, Steffick DE, Gadegbeku C et al. Graft and patient survival in kidney transplant recipients selected for de novo steroid-free maintenance immunosuppression. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2009; 9 (1): 160-168.
Jaber JJ, Feustel PJ, Elbahloul O et al. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol. Clinical transplantation 2007; 21 (1): 101-109.
Serrano OK, Kandaswamy R, Gillingham K et al. Rapid Discontinuation of Prednisone in Kidney Transplant Recipients: 15-Year Outcomes From the University of Minnesota. Transplantation 2017; 101 (10): 2590-2598.
- Abstract Viewed: 57 times
- Just Accepted-7493 Downloaded: 27 times